Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, B-Cell × etoposide phosphate × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 3 Leukemia 3 Central Nervous System Neoplasms 3 Brain Neoplasms 3 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Glioma 2 Burkitt Lymphoma 2 Astrocytoma 2 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Rhabdoid Tumor 1 Recurrence 1 Pinealoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Nervous System Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Lymphoma, B-Cell 1 Leukemia, Myeloid 1

Interventions

Cyclophosphamide 36 fludarabine 28 Rituximab 25 obinutuzumab 10 fludarabine phosphate 9 Bendamustine Hydrochloride 9 pembrolizumab 7 Vincristine 6 Specimen Handling 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Leukapheresis 6 Lenalidomide 6 Etoposide 6 venetoclax 5 ibrutinib 5 Inotuzumab Ozogamicin 5 Doxorubicin 5 Biopsy 5 ublituximab 4 tazemetostat 4 glofitamab 4 Interleukin-2 4 polatuzumab vedotin 3 Radiation 3 Nivolumab 3 Ipilimumab 3 Immunotherapy, Adoptive 3 Gemcitabine 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05270057 2025-10-09

LONCA

Medical College of Wisconsin

Phase 1 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡